Cost-effectiveness and cost-utility of a community pharmacist intervention in patients with depression (PRODEFAR study)
Main Authors: | Maria Rubio-Valera, Ana Fernández, Judith Bosmans, Maite Peñarrubia-Maria, Marian March, Juan Bellon, Antoni Serrano-Blanco |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2014-12-01
|
Series: | International Journal of Integrated Care |
Subjects: | |
Online Access: | http://www.ijic.org/articles/1953 |
Similar Items
-
Cost-effectiveness and cost-utility of a community pharmacist intervention in patients with depression (PRODEFAR study)
by: Maria Rubio-Valera, et al.
Published: (2014-12-01) -
Correction: Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study).
by: Maria Rubio-Valera, et al.
Published: (2016-01-01) -
Improving Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care: Pilot trial of a complex intervention
by: Carmen Corral-Partearroyo, et al.
Published: (2022-12-01) -
Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study)
by: Alba Sánchez-Viñas, et al.
Published: (2022-07-01) -
Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
by: Céline K. Stäuble, et al.
Published: (2021-12-01)